17 October 2021 - The Australian Government has secured access to two additional COVID-19 treatments to support the National Plan to Transition Australia’s COVID-19 response, following expert medical advice.

Under a new management with Roche, Australia will be supplied with 15,000 doses of the COVID-19 antibody based therapy, Ronapreve.

First supply of this treatment is expected to be available by the end of this month through an initial shipment of 5,000 doses and will be held in the National Medical Stockpile.

Read Minster of Health article